ArticlePLoS pathogens2010
Paramyxovirus entry and targeted vectors for cancer therapy.
Article in PLoS pathogens, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Anti-cancer efficacy of combined vaccine-strain measles and mumps viruses against colorectal cancer: an experimental study.Molecular biology reports · 2026Article
- The multi-faceted roles of R2TP complex span across regulation of gene expression, translation, and protein functional assembly.Biophysical reviews · 2023Review
- Article
- Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors.Molecular therapy oncolytics · 2016Article
- Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing.Molecular therapy. Methods & clinical development · 2016Article
- CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2014Article
- Structural basis of efficient contagion: measles variations on a theme by parainfluenza viruses.Current opinion in virology · 2014Review
- Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins.Gene therapy · 2013Article
- Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system.Molecular cancer · 2012Article
- Non-human viruses developed as therapeutic agent for use in humans.Reviews in medical virology · 2011Review
- MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.Molecular therapy : the journal of the American Society of Gene Therapy · 2011Article
- Measles virus fusion shifts into gear.Nature structural & molecular biology · 2011Article
- The heads of the measles virus attachment protein move to transmit the fusion-triggering signal.Nature structural & molecular biology · 2011Article
- Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.Molecular therapy oncolyticsArticle
- Oncolysis by paramyxoviruses: preclinical and clinical studies.Molecular therapy oncolyticsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.